Followers | 191 |
Posts | 6888 |
Boards Moderated | 0 |
Alias Born | 10/05/2010 |
![](https://investorshub.advfn.com/uicon/220422.png?cb=1622489011)
Friday, September 20, 2019 3:46:04 PM
On the three-year Weekly chart, the RSI is low at 36, the shares remain below the 50wma and broke below the 200wma in July, the MACD is inconclusive. There is a historical support range from 2017 between .50 and .65.
http://schrts.co/DfNeTBmY
Zooming in a bit on the Weekly, the RSI remains at 36, the 20/50wma Death Cross from November remains with the stock still below both moving averages. Although the MACD had a Signal Line Crossover in August the separation remains negligible. The stock has bounced at .60 twice since July making it a reasonable support level for now.
http://schrts.co/tvBrxxyf
Moving to the Daily chart, the RSI is low at 39, the 50/200dma Death Cross from November 2018 remains with the shares still trading below both moving averages. The last bounce to .73 created a Bullish MACD Signal Line Crossover which appears to be fading.
http://schrts.co/AYAKAkuh
Zooming in the RSI is 39, the 20/50dma death cross remains even with the pop in August and the stock remains below both moving averages. The Bullish MACD Signal Line Crossover from a week ago is giving up ground and I expect it to fail.
http://schrts.co/KkCjwyMS
Although the company has made some strides towards increasing revenues (I use ChrgD+ daily) it remains off of the radar of most investors/traders. The new licensees coming on-line Q4 through Q2 2020 should bring both revenues and attention to the company; I expect this will turn the chart around. The Patent portfolio is both proven and desirable making them an obvious acquisition target, eventually. I believe the wait for LXRP to turn around is nearing an end especially with the upcoming law changes in Canada. I continue to hold my long-term position and will add to it on occasion, when the chart reverses definitively I will be scooping up lots of shares.
Upcoming license PR link: https://www.otcmarkets.com/stock/LXRP/news/Lexaria-Bioscience-Summarizes-its-Eleven-Technology-Licenses?id=235543
All the best,
Knife
Recent LEXX News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/06/2024 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 07:28:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:30:59 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/16/2024 08:47:26 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:20:50 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 06:51:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 07:12:07 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/24/2024 06:33:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/18/2024 07:38:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 10:11:16 PM
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Drug-Delivery System Improves Way Molecules Enter Bloodstream • GlobeNewswire Inc. • 01/11/2024 01:30:00 PM
- Beyond Diabetes, a Blockbuster Horizon Beckons • InvestorsHub NewsWire • 01/10/2024 01:45:00 PM
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform • GlobeNewswire Inc. • 01/09/2024 01:30:00 PM
- Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs • InvestorsHub NewsWire • 01/08/2024 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:07:45 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/30/2023 09:14:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/20/2023 10:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 05:13:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 05:45:34 PM
- Get Ready for Next Generation of Diabetes, Weight-Management Drugs • InvestorsHub NewsWire • 11/01/2023 12:45:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM